Dynamic expression of SMAD3 is critical in osteoblast differentiation of PDMCs

Lin,Hsi‑Ting; Chen,Shao‑Kuan; Guo,Jiun‑Wen; Su,I‑Chang; Huang,Chi‑Jung; Chien,Chih‑Cheng; Chang,Chih‑Ju

doi:10.3892/ijmm.2018.4001

Dynamic expression of SMAD3 is critical in osteoblast differentiation of PDMCs

Authors:
- Hsi‑Ting Lin
- Shao‑Kuan Chen
- Jiun‑Wen Guo
- I‑Chang Su
- Chi‑Jung Huang
- Chih‑Cheng Chien
- Chih‑Ju Chang
View Affiliations

Affiliations: Department of Orthopedics, Cathay General Hospital, Taipei 10630, Taiwan, R.O.C., Department of Urology, Sijhih Cathay General Hospital, New Taipei City 22174, Taiwan, R.O.C., Ph.D. Program in Pharmaceutical Biotechnology, College of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan, R.O.C., Department of Neurosurgery, Sijhih Cathay General Hospital, New Taipei City 22174, Taiwan, R.O.C., School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan, R.O.C.
Published online on: November 26, 2018 https://doi.org/10.3892/ijmm.2018.4001
Pages: 1085-1093

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Human pluripotent stem cells have the potential assist in the identification of genes involved in mammalian development. The human placenta is considered a repository of stem cells, termed placenta‑derived multipotent cells (PDMCs), which are able to differentiate into cells with an osteoblastic phenotype. This plasticity of PDMCs maybe applied clinically to the understanding of osteogenesis and osteoporosis. In the presentstudy, osteoblasts were generated by culturing PDMCs in osteogenic medium. Reverse transcription quantitative polymerase chain reactionand the degree of osteoblast calcification were used to evaluate the efficacy of osteogenesis. The results suggestedthat the expression of mothers against decapentaplegic homolog 3 (SMAD3) increased in the initial stages of osteogenic differentiation but decreased in the later stages. However, osteogenesis was inhibitedwhen the PDMCs overexpressed SMAD3 throughout the differentiation period. In addition, the rate of osteogenic differentiation was decreased when SMAD3 signaling was impaired. In conclusion, SMAD3 serves an important role in osteoblast differentiation and bone formation in a time‑dependent manner. The data from the present study indicate that arapid increase in SMAD3 expression is crucial for osteogenesis and suggest a role for PDMCs in the treatment of patients with osteoporosis.

View Figures

View References

1	Guo G, von Meyenn F, Santos F, Chen Y, Reik W, Bertone P, Smith A and Nichols J: Naive pluripotent stem cells derived directly from isolated cells of the human inner cell mass. Stem Cell Reports. 6:437–446. 2016. View Article : Google Scholar : PubMed/NCBI
2	Zhu Z and Huangfu D: Human pluripotent stem cells: An emerging model in developmental biology. Development. 140:705–717. 2013. View Article : Google Scholar :
3	Correia C, Koshkin A, Carido M, Espinha N, Šarić T, Lima PA, Serra M and Alves PM: Effective hypothermic storage of human pluripotent stem cell-derived cardiomyocytes compatible with global distribution of cells for clinical applications and toxicology testing. Stem Cells Transl Med. 5:658–669. 2016. View Article : Google Scholar
4	Choudhary P, Booth H, Gutteridge A, Surmacz B, Louca I, Steer J, Kerby J and Whiting PJ: Directing differentiation of pluripotent stem cells toward retinal pigment epithelium lineage. Stem Cells Transl Med. 6:490–501. 2017. View Article : Google Scholar : PubMed/NCBI
5	Li P, Yang YM, Sanchez S, Cui DC, Dang RJ, Wang XY, Lin QX, Wang Y, Wang C, Chen DF, et al: Deubiquitinase MYSM1 is essential for normal bone formation and mesenchymal stem cell differentiation. Sci Rep. 6:222112016. View Article : Google Scholar : PubMed/NCBI
6	Dang PN, Dwivedi N, Phillips LM, Yu X, Herberg S, Bowerman C, Solorio LD, Murphy WL and Alsberg E: Controlled dual growth factor delivery from microparticles incorporated within human bone marrow-derived mesenchymal stem cell aggregates for enhanced bone tissue engineering via endochondral ossification. Stem Cells Transl Med. 5:206–217. 2016. View Article : Google Scholar
7	Cheng YC, Huang CJ, Lee YJ, Tien LT, Ku WC, Chien R, Lee FK and Chien CC: Knocking down of heat-shock protein 27 directs differentiation of functional glutamatergic neurons from placenta-derived multipotent cells. Sci Rep. 6:303142016. View Article : Google Scholar
8	Silva-Vargas V, Maldonado-Soto AR, Mizrak D, Codega P and Doetsch F: Age-dependent niche signals from the choroid plexus regulate adult neural stem cells. Cell Stem Cell. 19:643–652. 2016. View Article : Google Scholar
9	Hu K and Olsen BR: Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J Clin Invest. 126:509–526. 2016. View Article : Google Scholar
10	Jones DR: A potential osteoporosis target in the FAS ligand/FAS pathway of osteoblast to osteoclast signaling. Ann Transl Med. 3:1892015.
11	Bliuc D, Nguyen ND, Alarkawi D, Nguyen TV, Eisman JA and Center JR: Accelerated bone loss and increased post-fracture mortality in elderly women and men. Osteoporos Int. 26:1331–1339. 2015. View Article : Google Scholar
12	Pacifici R: Estrogen, cytokines, and Sathogenesis of SostPeno-pausal osteoporosis. J Bone Miner Res. 11:1043–1051. 1996. View Article : Google Scholar
13	Tanaka SM and Tachibana K: Frequency-dependence of mechanically stimulated osteoblastic calcification in tissue-engineered bone in vitro. Ann Biomed Eng. 43:2083–2089. 2015. View Article : Google Scholar
14	Amin Yavari S, Chai YC, Böttger AJ, Wauthle R, Schrooten J, Weinans H and Zadpoor AA: Effects of anodizing parameters and heat treatment on nanotopographical features, bioactivity, and cell culture response of additively manufactured porous titanium. Mater Sci Eng C Mater Biol Appl. 51:132–138. 2015. View Article : Google Scholar
15	Azuma K, Shiba S, Hasegawa T, Ikeda K, Urano T, Horie-Inoue K, Ouchi Y, Apizuka N and Inoue S: Osteoblast sSecific γ-glutamyl carboxylase deficient Pice disSlay enhanced bone forPation with aberrant mineralization. J Bone Miner Res. 30:1245–1254. 2015. View Article : Google Scholar
16	Nakamura T, Naruse M, Chiba Y, Komori T, Sasaki K, Iwamoto M and Fukumoto S: Novel hedgehog agonists promote osteoblast differentiation in mesenchymal stem cells. J Cell Physiol. 230:922–929. 2015. View Article : Google Scholar
17	Joensuu K, Uusitalo L, Alm JJ, Aro HT, Hentunen TA and Heino TJ: Enhanced osteoblastic differentiation and bone formation in co-culture of human bone marrow mesenchymal stromal cells and peripheral blood mononuclear cells with exogenous VEGF. Orthop Traumatol Surg Res. 101:381–386. 2015. View Article : Google Scholar
18	Willson T, Nelson SD, Newbold J, Nelson RE and LaFleur J: The clinical epidemiology of male osteoporosis: A review of the recent literature. Clin Epidemiol. 7:65–76. 2015.
19	Canalis E: MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis. Eur J Endocrinol. 178:R33–R44. 2018. View Article : Google Scholar
20	Ragsdale AB, Barringer TA III and Anastasio GD: Alendronate treatment to prevent osteoporotic fractures. Arch Fam Med. 7:583–586. 1998. View Article : Google Scholar
21	Kanis JA, Gertz BJ, Singer F and Ortolani S: Rationale for the use of alendronate in osteoporosis. Osteoporos Int. 5:1–13. 1995. View Article : Google Scholar
22	Drake MT, Clarke BL and Khosla S: Bisphosphonates: Mechanism of action and role in clinical practice. Mayo Clin Proc. 83:1032–1045. 2008. View Article : Google Scholar
23	Gertz BJ, Holland SD, Kline WF, Matuszewski BK and Porras AG: Clinical pharmacology of alendronate sodium. Osteoporos Int. 3(Suppl 3): S13–S16. 1993. View Article : Google Scholar
24	Porras AG, Holland SD and Gertz BJ: Pharmacokinetics of alendronate. Clin Pharmacokinet. 36:315–328. 1999. View Article : Google Scholar : PubMed/NCBI
25	Sui B, Hu C, Zhang X, Zhao P, He T, Zhou C, Qiu X, Chen N, Zhao X and Jin Y: Allogeneic mesenchymal stem cell therapy promotes osteoblastogenesis and prevents glucocorticoid-induced osteoporosis. Stem Cells Transl Med. 5:1238–1246. 2016. View Article : Google Scholar :
26	Qi X, Zhang J, Yuan H, Xu Z, Li Q, Niu X, Hu B, Wang Y and Li X: Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats. Int J Biol Sci. 12:836–849. 2016. View Article : Google Scholar : PubMed/NCBI
27	Cheng CC, Chung CA, Su LC, Chien CC and Cheng YC: Osteogenic differentiation of placenta-derived multipotent cells in vitro. Taiwan J Obstet Gynecol. 53:187–192. 2014. View Article : Google Scholar : PubMed/NCBI
28	Selim AO, Selim SA, Shalaby SM, Mosaad H and Saber T: Neuroprotective effects of placenta-derived mesenchymal stromal cells in a rat model of experimental autoimmune encephalomyelitis. Cytotherapy. 18:1100–1113. 2016. View Article : Google Scholar
29	Chien CC, Yen BL, Lee FK, Lai TH, Chen YC, Chan SH and Huang HI: In vitro differentiation of human placenta-derived multipotent cells into hepatocyte-like cells. Stem Cells. 24:1759–1768. 2006. View Article : Google Scholar
30	Yen BL, Huang HI, Chien CC, Jui HY, Ko BS, Yao M, Shun CT, Yen ML, Lee MC and Chen YC: Isolation of multipotent cells from human term placenta. Stem Cells. 23:3–9. 2005. View Article : Google Scholar
31	Lv FJ, Tuan RS, Cheung KM and Leung VY: Concise review: The surface markers and identity of human mesenchymal stem cells. Stem Cells. 32:1408–1419. 2014. View Article : Google Scholar
32	Ali H, Al-Yatama MK, Abu-Farha M, Behbehani K and Al Madhoun A: Multi-lineage differentiation of human umbilical cord Wharton's Jelly Mesenchymal Stromal cells mediates changes in the exSression Srofile of stePness Parkers. PLoS One. 10:e01224652015. View Article : Google Scholar
33	Wrobel E, Leszczynska J and Brzoska E: The characteristics of human bone-derived cells (HBDCS) during osteogenesis in vitro. Cell Mol Biol Lett. 21:262016. View Article : Google Scholar
34	Benisch P, Schilling T, Klein-Hitpass L, Frey SP, Seefried L, Raaijmakers N, Krug M, Regensburger M, Zeck S, Schinke T, et al: The transcriStional Srofile of PesenchyPal steP cell populations in primary osteoporosis is distinct and shows overexpression of osteogenic inhibitors. PLoS One. 7:e451422012. View Article : Google Scholar
35	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
36	Huang CJ, Lee CL, Yang SH, Chien CC, Huang CC, Yang RN and Chang CC: USregulation of the growth arrest sSecific 2 in recurrent colorectal cancers, and its susceptibility to chemotherapy in a model cell system. Biochim Biophys Acta. 1862:1345–1353. 2016. View Article : Google Scholar
37	Chen T, Mao H, Chen C, Wu L, Wang N, Zhao X, Qian J and Xing C: The role and mechanism of α Klotho in the calcification of rat aortic vascular smooth muscle cells. Biomed Res Int. 2015:1943622015. View Article : Google Scholar
38	Kaji H, Naito J, Sowa H, Sugimoto T and Chihara K: Smad3 differently affects osteoblast differentiation depending upon its differentiation stage. Horm Metab Res. 38:740–745. 2006. View Article : Google Scholar : PubMed/NCBI
39	Sowa H, Kaji H, Yamaguchi T, Sugimoto T and Chihara K: Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells. J Bone Miner Res. 17:1190–1199. 2002. View Article : Google Scholar
40	Jinnin M, Ihn H and Tamaki K: Characterization of SIS3, a novel sSecific inhibitor of SPad3, and its effect on transforPing growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol. 69:597–607. 2006. View Article : Google Scholar
41	Yang P, Lv S, Wang Y, Peng Y, Ye Z, Xia Z, Ding G, Cao X and Crane JL: Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice. Bone. 114:1–13. 2018. View Article : Google Scholar
42	Khan MP, Singh AK, Singh AK, Shrivastava P, Tiwari MC, Nagar GK, Bora HK, Parameswaran V, Sanyal S, Bellare JR and Chattopadhyay N: Odanacatib restores trabecular bone of skeletally mature female rabbits with osteopenia but induces brittleness of cortical bone: A comparative study of the investigational drug with PTH, Estrogen, and Alendronate. J Bone Miner Res. 31:615–629. 2016. View Article : Google Scholar
43	Ishijima M, Sakamoto Y, Yamanaka M, Tokita A, Kitahara K, Kaneko H and Kurosawa H: Minimum required vitamin D level for optimal increase in bone mineral density with alendronate treatment in osteoporotic women. Calcif Tissue Int. 85:398–404. 2009. View Article : Google Scholar
44	Park JH, Park KH, Cho S, Choi YS, Seo SK, Lee BS and Park HS: Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women. Menopause. 20:747–753. 2013. View Article : Google Scholar
45	Chou MT, Chang SN, Ke C, Chang HI, Sung ML, Kuo HC and Chen CN: The proliferation and differentiation of placental-derived multipotent cells into smooth muscle cells on fibrillar collagen. BioPaterials. 31(4367): 43752010.
46	Sun J, Li J, Li C and Yu Y: Role of bone morphogenetic protein-2 in osteogenic differentiation of mesenchymal stem cells. Mol Med Rep. 12:4230–4237. 2015. View Article : Google Scholar : PubMed/NCBI
47	Ho SS, Vollmer NL, Refaat MI, Jeon O, Alsberg E, Lee MA and Leach JK: Bone morphogenetic protein-2 promotes human mesenchymal stem cell survival and resultant bone formation when entrapped in photocrosslinked alginate hydrogels. Adv Healthc Mater. 5:2501–2509. 2016. View Article : Google Scholar
48	Baas J, Vestermark M, Jensen T, Bechtold J, Soballe K and Jakobsen T: Topical bisphosphonate augments fixation of bone-grafted hydroxyapatite coated implants, BMP-2 causes resorption-based decrease in bone. Bone. 97:76–82. 2017. View Article : Google Scholar
49	Liu Z, Yao X, Yan G, Xu Y, Yan J, Zou W and Wang G: Mediator MED23 cooperates with RUNX2 to drive osteoblast differentiation and bone development. Nat Commun. 7:111492016. View Article : Google Scholar
50	Zhao L, Jiang S and Hantash BM: Transforming growth factor beta1 induces osteogenic differentiation of murine bone marrow stromal cells. Tissue Eng Part A. 16:725–733. 2010. View Article : Google Scholar
51	Genge BR, Sauer GR, Wu LN, McLean FM and Wuthier RE: Correlation between loss of alkaline phosphatase activity and accumulation of calcium during matrix vesicle-mediated mineralization. J Biol Chem. 263:18513–18519. 1988.PubMed/NCBI
52	Bobryshev YV, Orekhov AN, Sobenin I and Chistiakov DA: Role of bone-type tissue-nonspecific alkaline phosphatase and PHOSPO1 in vascular calcification. Curr PharP Des. 20:5821–5828. 2014. View Article : Google Scholar
53	Sila-Asna M, Bunyaratvej A, Maeda S, Kitaguchi H and Bunyaratavej N: Osteoblast differentiation and bone formation gene expression in strontium-inducing bone marrow mesenchymal stem cell. Kobe J Med Sci. 53:25–35. 2007.
54	Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP and McNamara LM: Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a siPSlified bone niche. Eur Cell Mater. 23:13–27. 2012. View Article : Google Scholar
55	Yu Y, Yang JL, Chapman-Sheath PJ and Walsh WR: TGF-beta, BMPS, and their signal transducing mediators, Smads, in rat fracture healing. J Biomed Mater Res. 60:392–397. 2002. View Article : Google Scholar : PubMed/NCBI
56	Chen G, Deng C and Li YP: TGF-β and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 8:272–288. 2012. View Article : Google Scholar
57	Bonniaud P, Margetts PJ, Ask K, Flanders K, Gauldie J and Kolb M: TGF beta and SPad3 signaling link inflaPPation to chronic fibrogenesis. J IPPunol. 175(5390): 53952005.
58	Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, Sung JJ and Lan HY: TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting PiR 29. J AP Soc NeShrol. 22(1462): 14742011.
59	Dobaczewski M, Bujak M, Li N, Gonzalez Quesada C, Mendoza LH, Wang XF and Frangogiannis NG: Smad3 signaling critically regulates fibroblast ShenotySe and function in healing myocardial infarction. Circ Res. 107:418–428. 2010. View Article : Google Scholar :
60	Flanders KC, Major CD, Arabshahi A, Aburime EE, Okada MH, Fujii M, Blalock TD, Schultz GS, Sowers A, Anzano MA, et al: Interference with transforming growth factor-beta/Smad3 signaling results in accelerated healing of wounds in previously irradiated skin. Am J Pathol. 163:2247–2257. 2003. View Article : Google Scholar
61	Borton AJ, Frederick JP, Datto MB, Wang XF and Weinstein RS: The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J Bone Miner Res. 16:1754–1764. 2001. View Article : Google Scholar
62	Yu FY, Xie CQ, Sun JT, Peng W and Huang XW: OverexSressed miR-145 inhibits osteoclastogenesis in RANKL-induced bone marrow-derived macrophages and ovariectomized mice by regulation of Smad3. Life Sci. 202:11–20. 2018. View Article : Google Scholar
63	Tamai R and Kiyoura Y: Alendronate augments lipid A-induced IL-1β release and Smad3/NLRP3/ASC-dependent cell death. Life Sci. 198:8–17. 2018. View Article : Google Scholar
64	Tamai R, Sugiyama A and Kiyoura Y: Alendronate regulates cytokine production induced by lipid A through nuclear factor-κB and SPad3 activation in huPan gingival fibroblasts. J Periodontal Res. 46:13–20. 2011. View Article : Google Scholar
65	Rizzoli R, Greenspan SL, Bone G III, Schnitzer TJ, Watts NB, Adami S, Foldes AJ, Roux C, Levine MA, Uebelhart B, et al: Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis. J Bone Miner Res. 17:1988–1996. 2002. View Article : Google Scholar : PubMed/NCBI
66	Uchida S, Taniguchi T, Shimizu T, Kakikawa T, Okuyama K, Okaniwa M, Arizono H, Nagata K, Santora AC, Shiraki M, et al: Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: A double-blind, randomized study. J Bone Miner Metab. 23:382–388. 2005. View Article : Google Scholar
67	Du X, Huang F, Zhang S, Yao Y, Chen Y, Chen Y, Huang H and Bai B: Carboxymethylcellulose with phenolic hydroxyl micro-caSsules enclosinggene Podified BMSCs for controlled BMP 2 release in vitro. Artif Cells Nanomed Biotechnol. 45:1710–1720. 2017. View Article : Google Scholar